SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr. Forthright who wrote (2320)7/1/1998 2:41:00 PM
From: dwlima  Read Replies (2) of 5402
 
i am a professional and a financial consultant. i have performed corporate valuations for major companies, however the biotech industry is not my specialty. i can say that i did do a valuation on DELL which i sent out to over 70 people which some of you may have.

when it comes to valuing SGNC, each analyst will dervive a very different value (no past sales info, hundreds of assumptions to derive future cash-flows, discount rates, etc.) and what will matter will be the value derived from some punk out of Wharton or the U of C (my lovely MBA school) will place on this company and will either spur tremendous buying/takeover or not.

so, the real problem is not for us the value this company, but rather for us to guess the value that the few key analysts will come up with. i hate to say it, but it in this case i do not think our guess as to a correct value will tell us anything.

sincerely
dwlima
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext